Expiration Date of Tender Offer for Houghton Mifflin Harcourt Extended to April 6, 2022
Veritas Capital's affiliate, Harbor Purchaser Inc., has extended its cash tender offer for Houghton Mifflin Harcourt Company (HMHC) shares to April 6, 2022, at $21.00 per share. The extension addresses an 'inside date condition' ensuring adequate time for debt financing marketing. By March 28, 2022, approximately 1,803,547 shares (0.6% of total) were tendered. The offer is not contingent on financing. Interested shareholders are encouraged to review the Offer documents filed with the SEC on March 7, 2022.
- Tender offer extended to allow satisfaction of financing conditions.
- Offer price of $21.00 per share may attract shareholder interest.
- Only 0.6% of outstanding shares tendered by the extension date.
- Extension may indicate challenges in securing shareholder interest.
Extension Allows for Satisfaction of Inside Date Condition in Connection with Transaction Financing as Outlined in Merger Agreement
The tender offer was extended to allow for the satisfaction of the inside date condition, which, as previously disclosed, prevents acceptance for payment of all Company Shares tendered pursuant to the offer prior to
The tender offer is being made pursuant to the tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) in the Tender Offer Statement on Schedule TO (together with any amendments or supplements thereto, the “Tender Offer Statement”) filed by Purchaser and its affiliate,
About
Veritas is a longstanding technology investor with a focus on companies operating at the intersection of technology and government. The firm invests in companies that provide critical products, software, and services, primarily technology and technology-enabled solutions, to government and commercial customers worldwide. Veritas seeks to create value by strategically transforming the companies in which it invests through organic and inorganic means.
Leveraging technology to make a positive impact across vitally important areas, such as healthcare, education, and national security, is core to Veritas. We are proud stewards of national assets, improving the quality of healthcare while reducing cost, advancing our educational system, and protecting our nation and allies. For more information, visit www.veritascapital.com.
Additional Information and Where to Find It
This communication does not constitute an offer to buy or solicitation of an offer to sell Company Shares. This communication is for informational purposes only. The tender offer is not being made to, nor will tenders be accepted from, or on behalf of, holders of Company Shares in any jurisdictions in which the making of the tender offer or the acceptance thereof would not comply with the laws of that jurisdiction.
The tender offer is being made pursuant to a Tender Offer Statement on Schedule TO (including an Offer to Purchase, a related Letter of Transmittal and certain other tender offer documents) filed by
View source version on businesswire.com: https://www.businesswire.com/news/home/20220329005578/en/
For
Media Inquiries:
VeritasCapital-SVC@SARDVERB.com
Investor Inquiries:
212-297-0720
info@okapipartners.com
Source:
FAQ
What is the new expiration date for the HMHC tender offer?
What is the offer price for HMHC shares?
How many HMHC shares have been tendered as of March 28, 2022?